EP Patent

EP2345408A2 — Acid labile drug formulations

Assigned to Dr Reddys Laboratories Ltd · Expires 2011-07-20 · 15y expired

What this patent protects

Pharmaceutical formulations comprise inert cores that are coated with a composition comprising an acid labile drug, further sequentially coated with a barrier or intermediate layer and an enteric coating layer. Coated cores may be further formulated to produce tablets or capsules…

USPTO Abstract

Pharmaceutical formulations comprise inert cores that are coated with a composition comprising an acid labile drug, further sequentially coated with a barrier or intermediate layer and an enteric coating layer. Coated cores may be further formulated to produce tablets or capsules.

Drugs covered by this patent

Patent Metadata

Patent number
EP2345408A2
Jurisdiction
EP
Classification
—
Expires
2011-07-20
Drug substance claim
No
Drug product claim
No
Assignee
Dr Reddys Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.